0.22
-0.1602(-42.14%)
Currency In USD
| Previous Close | 0 |
| Open | 0.38 |
| Day High | 0.38 |
| Day Low | 0.15 |
| 52-Week High | 19.9 |
| 52-Week Low | 0.15 |
| Volume | 169,446 |
| Average Volume | 114,328 |
| Market Cap | 994,994 |
| PE | 0.61 |
| EPS | 0.36 |
| Moving Average 50 Days | 0.6 |
| Moving Average 200 Days | 4.55 |
| Change | -0.16 |
If you invested $1000 in Biora Therapeutics, Inc. (BIOR) since IPO date, it would be worth $0.67 as of February 05, 2025 at a share price of $0.22. Whereas If you bought $1000 worth of Biora Therapeutics, Inc. (BIOR) shares 3 years ago, it would be worth $5.61 as of February 05, 2025 at a share price of $0.22.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Biora Therapeutics Undertakes Chapter 11 Sale Process to Position Business for Future Growth
GlobeNewswire Inc.
Dec 30, 2024 1:00 PM GMT
Sale process will help enable next stage of product development Secures up to $10.25 million in new financing to support ongoing business operations SAN DIEGO, Dec. 30, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (“Biora” or the “Company”), a
Biora Therapeutics to Report Third Quarter 2024 Financial Results and Provide Corporate Update
GlobeNewswire Inc.
Nov 07, 2024 9:30 PM GMT
SAN DIEGO, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company reimagining therapeutic delivery, today announced it will report financial results and provide a corporate update for the third quarter ended
Biora Therapeutics Announces $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
GlobeNewswire Inc.
Oct 29, 2024 12:00 PM GMT
SAN DIEGO, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company reimagining therapeutic delivery, today announced that it has entered into definitive agreements for the purchase and sale of 745,342 shares o
Data not available